ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,921,400 | -54.6% | 623,434 | -22.1% | 0.08% | -63.4% |
Q3 2022 | $8,640,000 | -5.3% | 800,000 | 0.0% | 0.23% | +16.4% |
Q2 2022 | $9,120,000 | +25.1% | 800,000 | 0.0% | 0.20% | +28.3% |
Q1 2022 | $7,288,000 | -38.9% | 800,000 | 0.0% | 0.15% | -17.4% |
Q4 2021 | $11,936,000 | -41.9% | 800,000 | 0.0% | 0.18% | -31.6% |
Q3 2021 | $20,560,000 | -1.5% | 800,000 | 0.0% | 0.27% | +25.1% |
Q2 2021 | $20,864,000 | -26.1% | 800,000 | 0.0% | 0.22% | -22.9% |
Q1 2021 | $28,240,000 | +39.9% | 800,000 | 0.0% | 0.28% | +73.3% |
Q4 2020 | $20,192,000 | -33.1% | 800,000 | 0.0% | 0.16% | -29.7% |
Q3 2020 | $30,168,000 | -11.9% | 800,000 | 0.0% | 0.23% | -26.8% |
Q2 2020 | $34,256,000 | – | 800,000 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
Navalign, LLC | 64,428 | $961,000 | 0.38% |
Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |